Smoldering-associated worsening (SAW) of multiple sclerosis (MS) deserves a broader, more comprehensive approach to diagnosis, treatment, and research that goes beyond neurologists’ understanding of ...

Sanofi has launched an educational campaign to raise awareness about smoldering multiple sclerosis (MS), the lesser known of two processes that cause the neurological disease. Unlike acute MS, which ...

Prospective tracking of "smoldering" chronic active lesions with notable darkened rims in people with multiple sclerosis (MS), previously only detectable upon autopsy, suggests the lesions are linked ...

Treatments for multiple sclerosis have long focused on slowing or stopping the acute disease process, which moves quickly and causes symptom relapses and visible changes on MRI scans. In recent years, ...

Panelists discuss how progression independent of relapse activity (PIRA) represents a distinct pathological process involving smoldering inflammation and neurodegeneration that drives disability in ...

New clinical trial data suggest vidofludimus calcium can target key mechanisms underlying progressive multiple sclerosis.